Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli

Metabolic Engineering

Volumn 12, Issue 3, 2010, Pages 298-305

  Moon, Tae Seok ^a,b   Dueber, John E ^a,c   Shiue, Eric ^a,b   Prather, Kristala L Jones ^a,b  

^a NSF Synthetic Biology Engineering Research Center (SynBERC)   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c University of California at Berkeley   (United States)

Author keywords

Colocalization; Glucaric acid; Metabolic pathway engineering; Modularity; Scaffold; Synthetic biology

Indexed keywords

COLOCALIZATION; CONCENTRATION OF; E. COLI; EFFECTIVE CONCENTRATION; GLUCARIC ACID; HETEROLOGOUS EXPRESSION; IMPROVED SYNTHETIC ROUTE; INTERACTION DOMAIN; LIMITING FLUX; METABOLIC ENGINEERING; METABOLIC PATHWAY ENGINEERING; MYO-INOSITOL; MYO-INOSITOL OXYGENASE; PROTEIN-PROTEIN INTERACTIONS; SMALL MOLECULES; SYNTHETIC BIOLOGY; SYNTHETIC PATHWAYS; SYNTHETIC SCAFFOLDS; VALUE-ADDED CHEMICALS;

ACIDS; ALCOHOLS; CATALYSTS; COMPLEXATION; ENZYMES; ESCHERICHIA COLI; GLUCOSE; METABOLISM; MOLECULAR WEIGHT;

SCAFFOLDS;

GLUCOSE; INOSITOL; INOSITOL OXYGENASE; SACCHARIC ACID; SCAFFOLD PROTEIN;

ARTICLE; ESCHERICHIA COLI; METABOLIC ENGINEERING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; ESCHERICHIA COLI; GLUCARIC ACID; GLUCOSE; INOSITOL; INOSITOL OXYGENASE; PROTEIN INTERACTION DOMAINS AND MOTIFS; SWINE;

EID: 77950863739     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2010.01.003     Document Type: Article

References (45)

1. Alper H., et al. Tuning genetic control through promoter engineering. Proc. Natl. Acad. Sci. USA 102 (2005) 12678-12683
2. Arkin A.P., and Fletcher D.A. Fast, cheap and somewhat in control. Genome Biol. 7 (2006) 114
3. Arner R.J., et al. Molecular cloning, expression, and characterization of myo-inositol oxygenase from mouse, rat, and human kidney. Biochem. Biophys. Res. Commun. 324 (2004) 1386-1392
4. Atsumi S., et al. Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature 451 (2008) 86-89
5. Benner S.A., and Sismour A.M. Synthetic biology. Nat. Rev. Genet. 6 (2005) 533-543
6. Bentley W.E., et al. Plasmid-encoded protein: the principal factor in the metabolic burden associated with recombinant bacteria. Biotechnol. Bioeng. 35 (1990) 668-681
7. Birnbaum S., and Bailey J.E. Plasmid presence changes the relative levels of many host cell proteins and ribosome components in recombinant Escherichia coli. Biotechnol. Bioeng. 37 (1991) 736-745
8. Bloom J.D., et al. Evolving strategies for enzyme engineering. Curr. Opin. Struct. Biol. 15 (2005) 447-452
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
10. Brown P.M., et al. Crystal structure of a substrate complex of myo-inositol oxygenase, a di-iron oxygenase with a key role in inositol metabolism. Proc. Natl. Acad. Sci. USA 103 (2006) 15032-15037
11. Burack W.R., and Shaw A.S. Signal transduction: hanging on a scaffold. Curr. Opin. Cell Biol. 12 (2000) 211-216
12. DeLisa M.P., and Conrado R.J. Synthetic metabolic pipelines. Nat. Biotechnol. 27 (2009) 728-729
13. Dueber J.E., et al. Synthetic protein scaffolds provide modular control over metabolic flux. Nat. Biotechnol. 27 (2009) 753-759
14. Jones K.L., et al. Low-copy plasmids can perform as well as or better than high-copy plasmids for metabolic engineering of bacteria. Metab. Eng. 2 (2000) 328-338
15. Kane J.F., and Hartley D.L. Formation of recombinant protein inclusion bodies in Escherichia coli. Trends Biotechnol. 6 (1988) 95-101
16. Keasling J.D. Synthetic biology for synthetic chemistry. ACS Chem. Biol. 3 (2008) 64-76
17. Leonard E., et al. Engineering microbes with synthetic biology frameworks. Trends Biotechnol. 26 (2008) 674-681
18. Levchenko A., et al. Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc. Natl. Acad. Sci. USA 97 (2000) 5818-5823
19. Martin V.J., et al. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat. Biotechnol. 21 (2003) 796-802
20. Matsuhisa A., et al. Inositol monophosphatase activity from the Escherichia coli suhB gene product. J. Bacteriol. 177 (1995) 200-205
21. Menzella H.G., et al. Combinatorial polyketide biosynthesis by de novo design and rearrangement of modular polyketide synthase genes. Nat. Biotechnol. 23 (2005) 1171-1176
22. Moon T.S., et al. Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli. Appl. Environ. Microbiol. 75 (2009) 589-595
23. Moon T.S., et al. Enzymatic assay of d-glucuronate using uronate dehydrogenase. Anal. Biochem. 392 (2009) 183-185
24. Nakamura C.E., and Whited G.M. Metabolic engineering for the microbial production of 1,3-propanediol. Curr. Opin. Biotechnol. 14 (2003) 454-459
25. Niu W., et al. Microbial synthesis of the energetic material precursor 1,2,4-butanetriol. J. Am. Chem. Soc. 125 (2003) 12998-12999
26. Park S.H., et al. Rewiring MAP kinase pathways using alternative scaffold assembly mechanisms. Science 299 (2003) 1061-1064
27. Pawson T., and Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 300 (2003) 445-452
28. Pfleger B.F., et al. Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes. Nat. Biotechnol. 24 (2006) 1027-1032
29. Pitera D.J., et al. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab. Eng. 9 (2007) 193-207
30. Prather K.L.J., and Martin C.H. De novo biosynthetic pathways: rational design of microbial chemical factories. Curr. Opin. Biotechnol. 19 (2008) 468-474
31. Ro D.K., et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440 (2006) 940-943
32. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor
33. Sauer M., et al. Microbial production of organic acids: expanding the markets. Trends Biotechnol. 26 (2008) 100-108
34. Singh J., and Gupta K.P. Calcium glucarate prevents tumor formation in mouse skin. Biomed. Environ. Sci. 16 (2003) 9-16
35. Singh J., and Gupta K.P. Induction of apoptosis by calcium d-glucarate in 7,12-dimethyl benz [a] anthracene-exposed mouse skin. J. Environ. Pathol. Toxicol. Oncol. 26 (2007) 63-73
36. Stephanopoulos G. Metabolic fluxes and metabolic engineering. Metab. Eng. 1 (1999) 1-11
37. Stephanopoulos G., and Jensen K.L. Metabolic engineering: developing new products and processes by constructing functioning biosynthetic pathways in vivo. AIChE J. 51 (2005) 3091-3093
38. Tyo K.E., et al. Stabilized gene duplication enables long-term selection-free heterologous pathway expression. Nat. Biotechnol. 27 (2009) 760-765
39. Tyo K.E., et al. Expanding the metabolic engineering toolbox: more options to engineer cells. Trends Biotechnol. 25 (2007) 132-137
40. Walaszek Z., et al. d-Glucaric acid content of various fruits and vegetables and cholesterol-lowering effects of dietary-glucarate in the rat. Nutr. Res. 16 (1996) 673-681
41. Werpy, T., Petersen, G., 2004. In: N.R.E.L. (NREL) and P.N.N.L. (PNNL) (Eds.), Top Value added Chemicals from Biomass, vol. I: Results of Screening for Potential Candidates from Sugars and Synthesis Gas.
42. Xing G., et al. Oxygen activation by a mixed-valent, diiron(II/III) cluster in the glycol cleavage reaction catalyzed by myo-inositol oxygenase. Biochemistry 45 (2006) 5402-5412
43. Xing G., et al. Evidence for C-H cleavage by an iron-superoxide complex in the glycol cleavage reaction catalyzed by myo-inositol oxygenase. Proc. Natl. Acad. Sci. USA 103 (2006) 6130-6135
44. Xing G., et al. A coupled dinuclear iron cluster that is perturbed by substrate binding in myo-inositol oxygenase. Biochemistry 45 (2006) 5393-5401
45. Yoon S.H., et al. Cloning and characterization of uronate dehydrogenases from two pseudomonads and Agrobacterium tumefaciens strain C58. J. Bacteriol. 191 (2009) 1565-1573